The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for Abiomed’s Impella 2.5 heart pump during elective and urgent high-risk percutaneous coronary intervention (PCI) procedures.
Clearing blood clots (thrombectomy) from coronary arteries in about 20 percent of patients undergoing angioplasty appears to increase the risk of stroke without providing the intended benefit, according to a study presented at the 2015 American College of Cardiology (ACC) annual meeting.
A study in the March 24/31 issue of JAMA found that using balloon-expandable stents to treat symptomatic intracranial arterial stenosis resulted in an increased risk of stroke or transient ischemic attack (TIA). The study results support the use of medical therapy (clopidogrel and aspirin) as an alternative to balloon-expandable stents.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
atients with atrial fibrillation (AF) who received ablation while they were already undergoing surgery to correct a leaky mitral valve had fewer episodes of AF a year later compared to patients who had the valve surgery alone. This was according to a study presented at the American College of Cardiology (ACC) 2015 meeting.
A new study published online in the journal Radiology found a substantial gap between patient expectations and current practices for providing information about medical imaging tests that use radiation. Researchers said the findings highlight a need for better communication as medicine enters an era of patient-centered care.
Patients over age 80 with acute coronary syndromes would likely benefit from more invasive tests and therapies that may otherwise be denied them due to their age, according to research presented at the American College of Cardiology (ACC) 2015 annual meeting.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
atients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two coprimary endpoints — a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding — as compared to patients receiving standard anticoagulation therapy, according to a study presented at the 2015 American College of Cardiology (ACC) meeting.
Scientists from the U.S. Department of Energy’s Lawrence Berkeley National Laboratory have uncovered new clues about the risk of cancer from low-dose radiation. In this research, low-dose is defined as equivalent to 100 millisieverts or roughly the dose received from 10 full-body computed tomography (CT) scans.
TomTec Imaging Systems GmbH announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the latest version of its TomTec-Arena software solution.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its ProMRI Eluna pacemaker system. Biotronik ProMRI technology allows patients to undergo full-body magnetic resonance imaging (MRI) scans with both single-chamber (SR-T) and dual-chamber (DR-T) Eluna pacemakers when implanted with Setrox pacing leads.
AtriCure Inc. announced that it has launched the availability of its cryoICE cryo ablation probe (CRYO2) to provide cryoanalgesia for temporary pain management. AtriCure’s cryoICE is the first U.S. Food and Drug Administration (FDA)-cleared cryo ablation probe for the treatment of cardiac arrhythmias and for the temporary ablation of peripheral nerves to block pain.
Results of a clinical trial announced at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and effective for symptomatic advanced heart failure patients already receiving optimum drug and device therapy. The study also published in the Journal of the American College of Cardiology Heart Failure.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
A detailed reporting of the first successful case of a direct transcatheter tricuspid repair (TTVR) for severe TR has been reported by Prof. J. Schofer, M.D., of the Medicare Center and Department for Percutaneous Interventions of Structural Heart Disease, Albertinen Heart Center, Hamburg. Schofer’s report appears in the current issue of the peer-reviewed Journal of the American College of Cardiology (JACC).
The results from the CHAMPION Trial for the CardioMEMS device were presented at the American College of Cardiology (ACC) ...
Several late-breaking trials for transcatheter aortic valve replacement (TAVR) were presented at the American College of ...